Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 24 February, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 532644 | NSE: JKCEMENT

J K Cements Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 24, 2025, 1:40 pm

Market Cap 35,565 Cr.
Current Price 4,604
High / Low 4,989/3,639
Stock P/E56.4
Book Value 715
Dividend Yield0.33 %
ROCE15.8 %
ROE15.9 %
Face Value 10.0
PEG Ratio14.04

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for J K Cements Ltd

Competitors of J K Cements Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Bheema Cements Ltd 52.7 Cr. 16.2 35.3/16.2 13.20.00 %11.8 %56.4 % 10.0
UltraTech Cement Ltd 3,21,448 Cr. 11,135 12,145/9,25051.3 2,1260.63 %15.1 %12.2 % 10.0
The Ramco Cements Ltd 19,964 Cr. 844 1,060/700105 3020.30 %8.17 %5.63 % 1.00
The India Cements Ltd 7,963 Cr. 257 386/173 1700.00 %0.78 %4.81 % 10.0
Star Cement Ltd 8,650 Cr. 214 256/17264.9 67.90.00 %16.5 %11.5 % 1.00
Industry Average34,457.81 Cr1,888.4545.22530.040.67%11.09%16.06%7.13

All Competitor Stocks of J K Cements Ltd

Quarterly Result

MetricJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Sales 1,7141,8952,0302,3512,2722,2282,4362,7782,7632,7532,9353,1062,808
Expenses 1,3111,5651,6651,9671,8661,9232,1892,4282,3552,2862,3102,5462,321
Operating Profit 403330366384406305247350408467625560486
OPM % 24%17%18%16%18%14%10%13%15%17%21%18%17%
Other Income 27482642152219381729385545
Interest 62647173656779101109115114115110
Depreciation 81848791106106118132135141140153147
Profit before tax 28723023426225015469154181241409347273
Tax % 34%35%40%24%36%28%46%31%37%27%31%37%32%
Net Profit 19015014019916111137107113176284220185
EPS in Rs 24.8419.5918.4726.0321.0614.545.0514.1714.8422.6936.7328.4423.98

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 2,9072,7903,4014,3624,0104,8545,2595,8026,6067,9919,72011,55611,601
Expenses 2,3482,4372,9483,8163,2844,0644,4204,5565,0226,4788,3939,4859,463
Operating Profit 5593534535467267898391,2461,5851,5131,3272,0712,138
OPM % 19%13%13%13%18%16%16%21%24%19%14%18%18%
Other Income 474867507911076536711275129168
Interest 140153229305303284261276253270312453455
Depreciation 129134146197217231241288306342462573581
Profit before tax 338114144942863834127341,0931,0136281,1741,270
Tax % 32%34%2%41%40%25%36%34%36%33%34%33%
Net Profit 2307514255172286264483703679416790864
EPS in Rs 33.0011.0320.548.2725.4241.4134.9963.7391.8588.9354.82102.35111.84
Dividend Payout % 20%27%19%48%31%24%29%12%16%17%27%20%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-67.39%89.33%-61.27%212.73%66.28%-7.69%82.95%45.55%-3.41%-38.73%89.90%
Change in YoY Net Profit Growth (%)0.00%156.72%-150.60%273.99%-146.45%-73.97%90.65%-37.41%-48.96%-35.32%128.64%

J K Cements Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:15%
5 Years:17%
3 Years:20%
TTM:2%
Compounded Profit Growth
10 Years:27%
5 Years:25%
3 Years:3%
TTM:-8%
Stock Price CAGR
10 Years:21%
5 Years:26%
3 Years:18%
1 Year:6%
Return on Equity
10 Years:14%
5 Years:16%
3 Years:14%
Last Year:16%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 10:30 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 70707070707077777777777777
Reserves 1,6211,6761,5471,5171,6411,9052,6252,9503,6594,2484,6075,2905,449
Borrowings 1,3782,7833,2293,3233,3172,9412,9733,5033,6264,1155,2925,5495,738
Other Liabilities 9391,2341,2051,2751,3831,5411,7372,0112,5092,9633,3313,8864,111
Total Liabilities 4,0085,7646,0516,1856,4116,4567,4138,5429,87211,40313,30714,80215,375
Fixed Assets 2,3692,3274,0744,2544,5424,4434,5375,5545,9376,5448,4679,2989,472
CWIP 2551,7883373211271045745305091,032592464515
Investments 32683779801194384614221692368448
Other Assets 1,3521,5821,6031,5321,6621,7891,8632,4123,2833,6124,1554,6724,940
Total Assets 4,0085,7646,0516,1856,4116,4567,4138,5429,87211,40313,30714,80215,375

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +3823642565807728837041,3721,5938781,3771,959
Cash from Investing Activity +-527-1,558-478-408-668-79-825-1,483-1,348-984-1,964-1,626
Cash from Financing Activity +871,227230-193-346-723173-113-13762741-416
Net Cash Flow-58338-21-2428152-225108-44154-83

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow558.00351.00450.00543.00723.00787.00837.00-2.00-2.00-3.00-4.00-3.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days141519181818181720201818
Inventory Days438466345258292269257288257343223235
Days Payable187378196160222303179205204203188185
Cash Conversion Cycle26610216911688-1796100731595368
Working Capital Days-2-106-12-7-9-12-120583339
ROCE %16%7%8%8%12%14%13%17%20%17%10%16%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters57.62%51.50%45.82%45.84%45.84%45.84%45.83%45.80%45.80%45.70%45.70%45.70%
FIIs17.39%17.72%16.47%16.06%15.63%15.88%15.54%15.50%14.40%15.25%15.92%17.71%
DIIs20.10%19.82%20.65%21.09%21.91%21.85%22.46%23.15%24.25%24.01%23.37%22.06%
Public4.89%10.96%17.06%17.01%16.63%16.42%16.17%15.54%15.54%15.00%14.99%14.52%
No. of Shareholders78,50077,46190,70189,86282,39176,44475,76371,76472,58268,18177,58079,162

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Kotak Emerging Equity Fund - Regular Plan2,318,6162.081017.641,106,4052025-02-22109.56%
Axis Midcap Fund1,106,4051.61485.61,106,4052025-02-220%
DSP Mid Cap Fund987,6742.27433.491,106,4052025-02-22-10.73%
Kotak Equity Opportunities Fund - Regular Plan850,0001.55373.071,106,4052025-02-22-23.17%
SBI Magnum Midcap Fund713,7741.54313.281,106,4052025-02-22-35.49%
Mirae Asset Focused Fund509,8492.71223.771,106,4052025-02-22-53.92%
Kotak Small Cap Fund - Regular Plan504,9091.33221.61,106,4052025-02-22-54.36%
PGIM India Midcap Opportunities Fund500,2961.99219.581,106,4052025-02-22-54.78%
Canara Robeco Emerging Equities473,5320.87207.831,106,4052025-02-22-57.2%
Franklin India Prima Fund442,7391.62194.321,106,4052025-02-22-59.98%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 102.3555.1787.9090.9962.56
Diluted EPS (Rs.) 102.3555.1787.9090.9962.56
Cash EPS (Rs.) 176.34113.54132.25130.6299.83
Book Value[Excl.RevalReserv]/Share (Rs.) 688.71600.81555.29480.28389.22
Book Value[Incl.RevalReserv]/Share (Rs.) 688.71600.81555.29480.28389.22
Revenue From Operations / Share (Rs.) 1495.541257.981034.17854.96750.84
PBDIT / Share (Rs.) 285.34181.41210.34213.75168.09
PBIT / Share (Rs.) 211.24122.10166.02174.13130.82
PBT / Share (Rs.) 151.8881.70131.12141.4195.05
Net Profit / Share (Rs.) 102.2354.2487.9390.9962.56
NP After MI And SOA / Share (Rs.) 102.3555.1788.9391.8563.73
PBDIT Margin (%) 19.0714.4220.3325.0022.38
PBIT Margin (%) 14.129.7016.0520.3617.42
PBT Margin (%) 10.156.4912.6716.5412.65
Net Profit Margin (%) 6.834.318.5010.648.33
NP After MI And SOA Margin (%) 6.844.388.5910.748.48
Return on Networth / Equity (%) 14.739.0915.8818.9916.26
Return on Capital Employeed (%) 14.319.1214.6916.9915.04
Return On Assets (%) 5.343.206.027.185.76
Long Term Debt / Equity (X) 0.770.870.690.800.89
Total Debt / Equity (X) 0.971.070.890.840.95
Asset Turnover Ratio (%) 0.820.800.750.710.71
Current Ratio (X) 1.301.271.321.631.22
Quick Ratio (X) 0.950.930.861.240.84
Inventory Turnover Ratio (X) 1.651.321.241.401.39
Dividend Payout Ratio (NP) (%) 14.6527.1816.860.0027.46
Dividend Payout Ratio (CP) (%) 8.5013.1011.250.0017.32
Earning Retention Ratio (%) 85.3572.8283.140.0072.54
Cash Earning Retention Ratio (%) 91.5086.9088.750.0082.68
Interest Coverage Ratio (X) 4.874.496.036.534.70
Interest Coverage Ratio (Post Tax) (X) 2.762.343.523.782.75
Enterprise Value (Cr.) 35828.3326704.5122282.8724254.309489.25
EV / Net Operating Revenue (X) 3.102.752.793.671.64
EV / EBITDA (X) 16.2519.0513.7114.687.31
MarketCap / Net Operating Revenue (X) 2.732.322.353.381.25
Retention Ratios (%) 85.3472.8183.130.0072.53
Price / BV (X) 5.874.824.345.982.40
Price / Net Operating Revenue (X) 2.732.322.353.381.25
EarningsYield 0.020.010.030.030.06

After reviewing the key financial ratios for J K Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 102.35. This value is within the healthy range. It has increased from 55.17 (Mar 23) to 102.35, marking an increase of 47.18.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 102.35. This value is within the healthy range. It has increased from 55.17 (Mar 23) to 102.35, marking an increase of 47.18.
  • For Cash EPS (Rs.), as of Mar 24, the value is 176.34. This value is within the healthy range. It has increased from 113.54 (Mar 23) to 176.34, marking an increase of 62.80.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 688.71. It has increased from 600.81 (Mar 23) to 688.71, marking an increase of 87.90.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 688.71. It has increased from 600.81 (Mar 23) to 688.71, marking an increase of 87.90.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 1,495.54. It has increased from 1,257.98 (Mar 23) to 1,495.54, marking an increase of 237.56.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 285.34. This value is within the healthy range. It has increased from 181.41 (Mar 23) to 285.34, marking an increase of 103.93.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 211.24. This value is within the healthy range. It has increased from 122.10 (Mar 23) to 211.24, marking an increase of 89.14.
  • For PBT / Share (Rs.), as of Mar 24, the value is 151.88. This value is within the healthy range. It has increased from 81.70 (Mar 23) to 151.88, marking an increase of 70.18.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 102.23. This value is within the healthy range. It has increased from 54.24 (Mar 23) to 102.23, marking an increase of 47.99.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 102.35. This value is within the healthy range. It has increased from 55.17 (Mar 23) to 102.35, marking an increase of 47.18.
  • For PBDIT Margin (%), as of Mar 24, the value is 19.07. This value is within the healthy range. It has increased from 14.42 (Mar 23) to 19.07, marking an increase of 4.65.
  • For PBIT Margin (%), as of Mar 24, the value is 14.12. This value is within the healthy range. It has increased from 9.70 (Mar 23) to 14.12, marking an increase of 4.42.
  • For PBT Margin (%), as of Mar 24, the value is 10.15. This value is within the healthy range. It has increased from 6.49 (Mar 23) to 10.15, marking an increase of 3.66.
  • For Net Profit Margin (%), as of Mar 24, the value is 6.83. This value is within the healthy range. It has increased from 4.31 (Mar 23) to 6.83, marking an increase of 2.52.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 6.84. This value is below the healthy minimum of 8. It has increased from 4.38 (Mar 23) to 6.84, marking an increase of 2.46.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 14.73. This value is below the healthy minimum of 15. It has increased from 9.09 (Mar 23) to 14.73, marking an increase of 5.64.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 14.31. This value is within the healthy range. It has increased from 9.12 (Mar 23) to 14.31, marking an increase of 5.19.
  • For Return On Assets (%), as of Mar 24, the value is 5.34. This value is within the healthy range. It has increased from 3.20 (Mar 23) to 5.34, marking an increase of 2.14.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.77. This value is within the healthy range. It has decreased from 0.87 (Mar 23) to 0.77, marking a decrease of 0.10.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.97. This value is within the healthy range. It has decreased from 1.07 (Mar 23) to 0.97, marking a decrease of 0.10.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.82. It has increased from 0.80 (Mar 23) to 0.82, marking an increase of 0.02.
  • For Current Ratio (X), as of Mar 24, the value is 1.30. This value is below the healthy minimum of 1.5. It has increased from 1.27 (Mar 23) to 1.30, marking an increase of 0.03.
  • For Quick Ratio (X), as of Mar 24, the value is 0.95. This value is below the healthy minimum of 1. It has increased from 0.93 (Mar 23) to 0.95, marking an increase of 0.02.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.65. This value is below the healthy minimum of 4. It has increased from 1.32 (Mar 23) to 1.65, marking an increase of 0.33.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 14.65. This value is below the healthy minimum of 20. It has decreased from 27.18 (Mar 23) to 14.65, marking a decrease of 12.53.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 8.50. This value is below the healthy minimum of 20. It has decreased from 13.10 (Mar 23) to 8.50, marking a decrease of 4.60.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 85.35. This value exceeds the healthy maximum of 70. It has increased from 72.82 (Mar 23) to 85.35, marking an increase of 12.53.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 91.50. This value exceeds the healthy maximum of 70. It has increased from 86.90 (Mar 23) to 91.50, marking an increase of 4.60.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 4.87. This value is within the healthy range. It has increased from 4.49 (Mar 23) to 4.87, marking an increase of 0.38.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.76. This value is below the healthy minimum of 3. It has increased from 2.34 (Mar 23) to 2.76, marking an increase of 0.42.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 35,828.33. It has increased from 26,704.51 (Mar 23) to 35,828.33, marking an increase of 9,123.82.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.10. This value exceeds the healthy maximum of 3. It has increased from 2.75 (Mar 23) to 3.10, marking an increase of 0.35.
  • For EV / EBITDA (X), as of Mar 24, the value is 16.25. This value exceeds the healthy maximum of 15. It has decreased from 19.05 (Mar 23) to 16.25, marking a decrease of 2.80.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.73. This value is within the healthy range. It has increased from 2.32 (Mar 23) to 2.73, marking an increase of 0.41.
  • For Retention Ratios (%), as of Mar 24, the value is 85.34. This value exceeds the healthy maximum of 70. It has increased from 72.81 (Mar 23) to 85.34, marking an increase of 12.53.
  • For Price / BV (X), as of Mar 24, the value is 5.87. This value exceeds the healthy maximum of 3. It has increased from 4.82 (Mar 23) to 5.87, marking an increase of 1.05.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.73. This value is within the healthy range. It has increased from 2.32 (Mar 23) to 2.73, marking an increase of 0.41.
  • For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 23) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of J K Cements Ltd as of February 24, 2025 is: ₹5,146.39

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 24, 2025, J K Cements Ltd is Undervalued by 11.78% compared to the current share price ₹4,604.00

Intrinsic Value of J K Cements Ltd as of February 24, 2025 is: 5,353.11

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 24, 2025, J K Cements Ltd is Undervalued by 16.27% compared to the current share price ₹4,604.00

Last 5 Year EPS CAGR: 4.02%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of 8.58, which is a positive sign.
  2. The company has shown consistent growth in sales (5.62 cr) and profit (241.31 cr) over the years.
  1. The stock has a low average ROCE of 13.17%, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 106.08, which may not be favorable.
  3. The company has higher borrowings (3,674.38) compared to reserves (2,979.62), which may suggest financial risk.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in J K Cements Ltd:
    1. Net Profit Margin: 6.83%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 14.31% (Industry Average ROCE: 11.09%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 14.73% (Industry Average ROE: 14.99%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 2.76
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.95
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 56.4 (Industry average Stock P/E: 27.13)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.97
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

JK Cement Ltd. is a Public Limited Listed company incorporated on 24/11/1994 and has its registered office in the State of Uttar Pradesh, India. Company's Corporate Identification Number(CIN) is L17229UP1994PLC017199 and registration number is 017199. Currently Company is involved in the business activities of Manufacture of cement, lime and plaster. Company's Total Operating Revenue is Rs. 10918.05 Cr. and Equity Capital is Rs. 77.27 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
CementKamla Tower, Kanpur Uttar Pradesh 208001shambhu.singh@jkcement.com
http://www.jkcement.com
Management
NamePosition Held
Mrs. Sushila Devi SinghaniaChairperson
Dr. Nidhipati SinghaniaVice Chairman
Dr. Raghavpat SinghaniaManaging Director
Mr. Madhavkrishna SinghaniaDy.Managing Director & CEO
Mr. Ajay Kumar SaraogiDy.Managing Director & CFO
Mr. Mudit AggarwalDirector
Mr. Paul Heinz HugentoblerDirector
Mr. Saurabh ChandraDirector
Mrs. Deepa Gopalan WadhwaDirector
Mr. Ashok Kumar SharmaDirector
Mr. Ashok SinhaDirector
Mr. Sudhir JalanDirector
Ms. Praveen MahajanDirector
Mr. Rakesh SethiDirector

FAQ

What is the latest intrinsic value of J K Cements Ltd?

Let's break down J K Cements Ltd's intrinsic value simply:

We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.

As of 24 February 2025:

  • Calculated Fair Value: ₹5146.39
  • Current Market Price: ₹4,604.00
  • Variance: 11.78% higher

This suggests J K Cements Ltd is currently undervalued by 11.78%. For context:

  • Market Cap: 35,565 Cr.
  • 52-Week Range: 4,989/3,639
  • Reserves (Sep 2024): ₹5,449 Cr
  • Liabilities: 15,375 Cr

Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.

What is the Market Cap of J K Cements Ltd?

The Market Cap of J K Cements Ltd is 35,565 Cr..

What is the current Stock Price of J K Cements Ltd as on 24 February 2025?

The current stock price of J K Cements Ltd as on 24 February 2025 is ₹4,604.

What is the High / Low of J K Cements Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of J K Cements Ltd stocks is 4,989/3,639.

What is the Stock P/E of J K Cements Ltd?

The Stock P/E of J K Cements Ltd is 56.4.

What is the Book Value of J K Cements Ltd?

The Book Value of J K Cements Ltd is 715.

What is the Dividend Yield of J K Cements Ltd?

The Dividend Yield of J K Cements Ltd is 0.33 %.

What is the ROCE of J K Cements Ltd?

The ROCE of J K Cements Ltd is 15.8 %.

What is the ROE of J K Cements Ltd?

The ROE of J K Cements Ltd is 15.9 %.

What is the Face Value of J K Cements Ltd?

The Face Value of J K Cements Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in J K Cements Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE